Page 1
About your PSA result
A patient information leaflet explaining prostate specific antigen (PSA), how it is measured, and what elevated results may mean. It describes factors that affect PSA levels, repeat testing, specialist referral, and further investigations such as digital rectal examination, MRI and biopsy. It also outlines prostate cancer diagnosis, active surveillance, treatment considerations, and Australian information and support services. The leaflet emphasises that an abnormal PSA result does not necessarily mean prostate cancer.
The first 5 pages, shown as text so search engines and readers can find this document.
About your PSA result
What is PSA? Prostate specific antigen (PSA) is a protein made in the prostate gland. The prostate is a walnut-sized gland that sits below the bladder in front of the rectum. It surrounds the urethra, the passage in the penis through which urine and semen pass. PSA is produced by prostate cells and enters the blood stream. As men get older and the prostate gland grows larger, they may produce higher levels of PSA. However, higher levels of PSA can also be caused by other conditions. One of these is prostate cancer. An elevated PSA level means something is happening in the prostate gland and further investigation may be required. How is PSA measured? PSA is measured through a simple blood test. The initial PSA test usually measures the total PSA in the blood stream. Sometimes, if a person has an elevated total PSA, another blood test will be given to measure and compare the levels of two different forms of PSA - PSA bound to protein and free (non- bound) PSA. This is called the free to total PSA ratio. The free to total ratio can indicate whether the elevated PSA is more likely due to a benign (enlarged prostate) or a cancerous cause. What do the results mean? A PSA level that stays elevated suggests something is going on in the prostate and further tests are required to determine if it is cancer or something else. If your PSA level is over 3.0 ng/ml, your PSA test should be repeated within 1 to 3 months. This is because the PSA sometimes returns to normal levels. Your doctor may also order a free to total PSA ratio test. If the PSA is still elevated and the free to total ratio is low, then you may be referred to a specialist (urologist) for more tests. If you have a family history of prostate cancer and/or are aged in your 40s, your doctor may recommend further PSA testing if your PSA level is above 2.0 ng/ml. About your PSA result An abnormal PSA result does not necessarily mean you have prostate cancer.
What could affect my PSA level? A ‘normal’ PSA level is different for everyone. It depends on several things, including: • your age (the older you are, the higher your PSA level will be) • the size of your prostate (levels are higher with an enlarged prostate) • your ethnicity • medications you are taking • a urinary infection • certain types of exercise such as bicycle riding or vigorous exercise • how recently you had sex or ejaculated • anal sex or prostate stimulation. Other conditions that could cause an elevated PSA level are: Benign prostatic hyperplasia (BPH) or enlarged prostate: This is a common condition that happens when the prostate grows larger with age. It can affect urination. It is treated with medications or surgery. Prostatitis (infection or inflammation of the prostate): Prostatitis is when the prostate gland becomes inflamed and sore. It can be very painful and causes more frequent urination. It can be treated with antibiotics, other medications or surgery. In very rare cases men can have prostate cancer even if their PSA test result is normal. Talk to your doctor if you notice any worrying symptoms such as: • feeling the frequent or sudden need to urinate • finding it difficult to urinate (for example, trouble starting or not being able to urinate when the feeling is there or poor urine flow) • discomfort when urinating • finding blood in urine or semen • pain in the lower back, upper thighs or hips.
What are the next steps? Your doctor will consider the results of your repeat PSA test, as well as your age and family history before recommending the next steps for you. If your repeat PSA results are not cause for concern, talk to your doctor about future PSA testing. If your repeat PSA results still indicate a concern, your doctor will refer you to a urologist for further investigations. The urologist will likely perform a digital rectal examination (DRE). This is a procedure where a doctor inserts a gloved, lubricated finger into the rectum to feel the size and shape of the prostate gland. A normal DRE result does not necessarily rule out prostate cancer. If the DRE and/or your PSA tests indicate a possibility of prostate cancer, the next steps can include an MRI scan and/or a tissue biopsy. Magnetic resonance imaging (MRI) is a scan to assess the size of the prostate and look for any abnormal areas. An MRI is used to determine if a cancer is present and which part of the prostate it can be found in. This helps the urologist to decide whether a biopsy is needed and which area of the prostate to target for the biopsy. The MRI is performed as an outpatient procedure. Let your doctor know if you suffer from claustrophobia or if you have any metal implants, medical devices or have had joint surgery. A biopsy is a procedure where a needle is used to remove multiple small samples of tissue from the prostate gland. The samples are sent to a laboratory to be examined. This will show whether the cells in the prostate are malignant (cancerous) or benign (non-cancerous). A biopsy is the only way a definitive diagnosis of prostate cancer can be made. A biopsy can be performed either through the rectum under local anaesthetic or through the perineum under anaesthetic. If the biopsy is negative, you will probably be offered routine monitoring of your PSA levels. If subsequent tests show a rise in PSA levels, you may need another biopsy or MRI scan.
What if it’s prostate cancer? A positive biopsy is the only way to confirm that you have prostate cancer. The cancer grade, which is determined from the biopsy, gives an indication of how fast the cancer is growing. You may be required to have further tests to determine the stage of the cancer. The cancer stage indicates whether the cancer has remained within the prostate gland or has spread outside of the prostate to surrounding areas or other parts of the body. How your prostate cancer is treated will depend on your PSA results, the grade and stage of the cancer, your symptoms, your overall health and your personal preferences. If there is a low risk that your prostate cancer will cause you harm, you may be offered Active Surveillance. This involves regular testing to check for any changes to the cancer. If the cancer changes, you may need treatment. If your cancer is higher risk, you will be offered treatment. Different treatments come with differing side effects, some of which include urinary problems, erection and ejaculation problems, bowel problems, fatigue, depression and anxiety. You may need to meet with several different cancer specialists such as a urologist, radiation oncologist and/or medical oncologist to discuss your treatment options. More information can be found in Prostate cancer – a guide for newly-diagnosed men downloadable at prostate.org.au. Taking your partner, family member or a close friend with you when you see your doctor can be helpful when discussing your diagnosis and treatment options. Relative to the general population and taking into account other causes of death, 96% of men with prostate cancer will survive at least 5 years after diagnosis and 92% of men with prostate cancer will survive 10 years or more.
Doxxly editorial guide
This guide helps you understand the scope of About your PSA result before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.
About your PSA result is a 6-page documentcredited to Bram E. Kestrel. A patient information leaflet explaining prostate specific antigen (PSA), how it is measured, and what elevated results may mean. It describes factors that affect PSA levels, repeat testing, specialist referral, and further investigations such as digital rectal examination, MRI and biopsy. It also outlines prostate cancer diagnosis, active surveillance, treatment considerations, and Australian information and support services. The leaflet emphasises that an abnormal PSA result does not necessarily mean prostate cancer. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.
The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of PSA testing, Prostate health, Prostate cancer, Patient information, Diagnosis, Australian support services with the related resources linked below.
Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.
The catalogue connects this document with PSA testing, Prostate health, Prostate cancer, Patient information, Diagnosis, Australian support services. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.
A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.
The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 6 pages in the player.
Use this section of the reading guide to identify how PSA testing appears in About your PSA result, note important terms, and connect the subject to the wider purpose of the work.
Use this section of the reading guide to identify how Prostate health appears in About your PSA result, note important terms, and connect the subject to the wider purpose of the work.
Use this section of the reading guide to identify how Prostate cancer appears in About your PSA result, note important terms, and connect the subject to the wider purpose of the work.
Use this section of the reading guide to identify how Patient information appears in About your PSA result, note important terms, and connect the subject to the wider purpose of the work.
Use this section of the reading guide to identify how Diagnosis appears in About your PSA result, note important terms, and connect the subject to the wider purpose of the work.
Use this section of the reading guide to identify how Australian support services appears in About your PSA result, note important terms, and connect the subject to the wider purpose of the work.
When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.
Doxxly credits Bram E. Kestrel as the author or creator of About your PSA result. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.
Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.
The recorded source for this item is prostate.org.au. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.
Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.
Visit prostate.org.auBegin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.
The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.
If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.
As you read About your PSA result, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.
A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.
Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.
Practical answers about reading, downloading and understanding this document on Doxxly.
Dara R. Ingleby
Mira V. Thackery
Freya O. Bellweather
Talia B. Grayling
Quill Z. Merrick
Juno M. Ravenhill